The Health Resources and Services Administration is reminding hospitals that participate in the 340B drug savings program that they must recertify by Dec. 6 or they will be terminated from the program. HRSA is required to recertify annually all participating covered entities enrolled in the 340B program to ensure they are appropriately listed on the 340B database and that covered entities remain compliant with the 340B program requirements. This year, HRSA unveiled a new recertification process, and any hospital that recertified or started the recertification process before Nov. 3 must complete a new recertification by Dec. 6. For questions about the recertification process, please visit https://www.hrsa.gov/opa/340b-opais/index.html or contact the 340B Prime Vendor Program at (888) 340-2787 or at apexusanswers@340pvp.com. 

Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B…
Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The Centers for Medicare & Medicaid Services released a proposed rule Oct. 16 seeking to codify regulations that will improve the accuracy of Medicare…
Headline
The Centers for Medicare & Medicaid Services announced that it will exercise enforcement discretion for inpatient rehabilitation facility admissions from…